Advanced search
Publication Cover
Journal of Inflammation Research Volume 16, 2023 - Issue
Submit an article Journal homepage
136
Views
0
CrossRef citations to date
0
Altmetric
CASE REPORT

Concurrent Polycythemia Vera with Newly Diagnosed Multiple Myeloma: Case Report and Literature Review

Jing YuanDepartment of Hematology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050000, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0003-4499-1232
ORCID Icon,
Xuan LiuDepartment of Hematology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050000, People’s Republic of China
,
Zhenzhen WangDepartment of Hematology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050000, People’s Republic of China
,
Liyuan LiDepartment of Hematology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050000, People’s Republic of China
&
Fuxu WangDepartment of Hematology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050000, People’s Republic of ChinaCorrespondence[email protected]
Pages 4117-4121 | Received 28 Jul 2023, Accepted 13 Sep 2023, Published online: 18 Sep 2023

References

  • Spivak JL. Polycythemia vera. Blood. 2019;133(25):2630–2631. doi:10.1182/blood-2019-04-901132
  • McMullin MF, Wilkins BS, Harrison CN. Management of polycythaemia vera: a critical review of current data. Br J Haematol. 2016;172(3):337–349. doi:10.1111/bjh.13812
  • Barbui T, Barosi G, Birgegard G, et al. Philadelphia-negative classical myeloproliferative neoplasms: critical concepts and management recommendations from European LeukemiaNet. J Clin Oncol. 2011;29(6):761–770. doi:10.1200/JCO.2010.31.8436
  • Spivak JL. How I treat polycythemia vera. Blood. 2019;134(4):341–352. doi:10.1182/blood.2018834044
  • Rajkumar SV, Dimopoulos MA, Palumbo A, et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014;15(12):e538–e548. doi:10.1016/S1470-2045(14)70442-5
  • Röllig C, Knop S, Bornhäuser M. Multiple myeloma. Lancet. 2015;385(9983):2197–2208. doi:10.1016/S0140-6736(14)60493-1
  • Lawrence JH, Rosenthal RL. Multiple myeloma associated with polycythemia; report of four cases. Am J Med Sci. 1949;218(2):149–154. doi:10.1097/00000441-194908000-00005
  • Inase N, Shichiri M, Marumo F. Secondary polycythemia associated with multiple myeloma. Jpn J Med. 1989;28(3):396–398. doi:10.2169/internalmedicine1962.28.396
  • Chang H, Shih LY. Concurrence of multiple myeloma and idiopathic erythrocytosis. Acta Clin Belg. 2009;64(5):434–435. doi:10.1179/acb.2009.071
  • Hutchison EJ, Taverna JA, Yu Q, Yeager AM. Polycythaemia: an unusual presentation of multiple myeloma. BMJ Case Rep. 2016;bcr2016216686. doi:10.1136/bcr-2016-216686
  • Kelsey PR, Patel K. Coexistence of polycythaemia vera with indolent myeloma in the same patient. Hematology. 1997;2(2):139–142. doi:10.1080/10245332.1997.11746329
  • Fink L, Bauer F, Perry JJ. Coincidental polycythemia vera and multiple myeloma: case report and review. Am J Hematol. 1993;44(3):196–200. doi:10.1002/ajh.2830440311
  • Kyle RA, Gertz MA, Witzig TE, et al. Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc. 2003;78(1):21–33. doi:10.4065/78.1.21
  • Maeda K, Abraham J. Polycythemia associated with myeloma. Am J Clin Pathol. 1984;82(4):501–505. doi:10.1093/ajcp/82.4.501
  • Heinle EW, Sarasti HO, Garcia D, Kenny JJ, Westerman MP. Polycythemia vera associated with lymphomatous diseases and myeloma. Arch Intern Med. 1966;118(4):351–355. doi:10.1001/archinte.1966.00290160051010
  • Franzén S, Johansson B, Kaigas M. Primary polycythaemia associated with multiple myeloma. Acta Med Scand Suppl. 1966;445:336–343. doi:10.1111/j.0954-6820.1966.tb02380.x
  • Barbui T, Thiele J, Gisslinger H, et al. The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion. Blood Cancer J. 2018;8(2):15. doi:10.1038/s41408-018-0054-y
  • Vannucchi AM, Masala G, Antonioli E, et al. Increased risk of lymphoid neoplasms in patients with Philadelphia chromosome-negative myeloproliferative neoplasms. Cancer Epidemiol Biomarkers Prev. 2009;18(7):2068–2073. doi:10.1158/1055-9965.EPI-09-0353
  • Nielsen C, Birgens HS, Nordestgaard BG, Kjaer L, Bojesen SE. The JAK2 V617F somatic mutation, mortality and cancer risk in the general population. Hamatologica. 2011;96(3):450–453. doi:10.3324/haematol.2010.033191
  • Huang Q, Li X, Chen W, Weiss LM. Absence of JAK-2V617F point mutations in multiple myeloma. Leukemia. 2007;21(4):813–814. doi:10.1038/sj.leu.2404551
  • Vannucchi AM, Kiladjian JJ, Griesshammer M, et al. Ruxolitinib versus standard therapy for the treatment of polycythemia vera. N Engl J Med. 2015;372(5):426–435. doi:10.1056/NEJMoa1409002

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.